4th May 2026
30th April 2026
MPM has collected three China drugs for its ‘best of both worlds’ strategy
28th April 2026
US FDA Accepts New Drug Application for Cullinan Therapeutics’ Zipalertinib for Treatment of Non-Small Cell Lung Cancer
30th March 2026
Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519
18th March 2026
Crossbow Therapeutics Raises $77 Million in Series B Financing to Advance Development of TCR-mimetic Antibody Therapies to Treat Cancer
9th January 2026
Aktis Oncology Announces Pricing of its Upsized Initial Public Offering
16th December 2025
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
22nd September 2025
The Endpoints 11: Umoja Biopharma looks to finally break through the barriers that restrict CAR-T
16th September 2025
Reunion Neuroscience Announces Final Closing of its Series A Financing and Plans to Advance RE104 into Clinical Development for the Treatment of Generalized Anxiety Disorder (GAD)
18th August 2025